AI assistant
Sending…
RECURSION PHARMACEUTICALS, INC. — Director's Dealing 2026
Mar 4, 2026
31628_dirs_2026-03-04_60214852-9563-4aed-ba9b-625275d161aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK: 0001601830
Period of Report: 2026-03-03
Reporting Person: Borgeson Blake (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Class A Common Stock | S | 170000 | $3.46 | Disposed | 6259863 | Direct |
More from RECURSION PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20